Ivermectin is Now a Treatment Option for Health Care Providers
January 18th, 2021Via: Front Line Covid-19 Critical Care Alliance:
One week after Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH has upgraded their recommendation and now considers Ivermectin an option for use in COVID-19.
Their recommendation has now been upgraded to the same level as those for widely used monoclonal antibodies & convalescent plasma, which is a “neither for nor against” recommendation. The significance of this change is that the NIH has decided to no longer recommend against the use of ivermectin in the treatment of COVID-19 by the nation’s health care providers. A consequence of this change is that ivermectin has now been made a clear therapeutic option for patients.
https://www.sciencedirect.com/science/article/pii/S0166354220302011
Antiviral Research Volume 178, June 2020,
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
“Highlights:
Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2) in vitro.
A single treatment able to effect ~5000-fold reduction in virus at 48 h in cell culture.
Ivermectin is FDA-approved for parasitic infections, and therefore has a potential for repurposing.
Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines.”
I have been waiting to hear more about this since running across the above last year. I guess we can’t have the above average flu suddenly thwarted by a track record therapy. No, in the pursuit of Science, we need data on the latest and greatest. Our need is so great, large scale trials with indemnity shall be the public’s duty. Pay no attention to the cure behind the curtain, I am the great and powerful mRNA!